DLL3 as a candidate gene for vertebral malformations

Philip F Giampietro1, Cathleen L Raggio, Cory Reynolds

  • 1Department of Medical Genetic Services, Marshfield Clinic, Marshfield, Wisconsin 54449, USA. giampietro.philip@marshfieldclinic.org

Insights

Researchers investigated mutations in the DLL3 gene, part of the notch-signaling pathway, for links to congenital vertebral malformations. A novel missense mutation was identified in a patient, suggesting DLL3 as a potential genetic factor in these conditions.

Area of Science:

  • Genetics
  • Developmental Biology
  • Molecular Biology

Background:

  • Congenital vertebral malformations lack a clearly identified major genetic locus.
  • The notch-signaling pathway plays a crucial role in embryonic development.

Observation:

  • Based on mouse models, a hypothesis was formed linking DLL3 mutations to human vertebral malformations.
  • The DLL3 gene was sequenced in 50 patients with congenital vertebral malformations.

Findings:

  • A heterozygous missense mutation (G to A) in DLL3, changing glycine to arginine at codon 269, was found in a VACTERL patient with block vertebrae.
  • This specific mutation was absent in 87 anonymous individuals from a control population.
  • The patient's asymptomatic mother also carried the heterozygous missense mutation.

Implications:

  • The identified DLL3 mutation may be a clinically significant factor in congenital vertebral malformations.
  • Further research is needed to confirm causality, potentially through larger population studies or functional analyses.
  • Mechanisms like susceptibility alleles, somatic mosaicism, or multigenic inheritance could explain the mutation's presence in an asymptomatic carrier.